Wednesday, November 29, 2023 8:54:04 AM
Recent VVOS News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:15:35 PM
- Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance • GlobeNewswire Inc. • 06/12/2024 11:30:00 AM
- Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors • GlobeNewswire Inc. • 05/20/2024 05:04:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:43:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 06:54:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:16:08 PM
- Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement • GlobeNewswire Inc. • 04/09/2024 11:30:00 AM
- Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 03/28/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call • GlobeNewswire Inc. • 03/28/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 01:55:42 PM
- Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 10:42:51 PM
- Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities • GlobeNewswire Inc. • 02/06/2024 12:30:00 PM
- Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA • GlobeNewswire Inc. • 01/08/2024 12:30:00 PM
- Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway” • GlobeNewswire Inc. • 12/11/2023 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/04/2023 05:15:05 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 12/01/2023 09:12:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 09:05:34 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/30/2023 09:03:04 PM
- Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea • GlobeNewswire Inc. • 11/29/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/22/2023 09:46:39 PM
- Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 11/14/2023 09:05:00 PM
- Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call • GlobeNewswire Inc. • 11/09/2023 09:30:00 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM